Vishal Dhikale, Associate Vice President at Avalon Consulting, unpacks the implications of impending US reciprocal tariffs on India’s export-driven bioscience sector. In BioVoice News, he highlights how rising input costs, disrupted supply chains, and regulatory uncertainty threaten India’s global competitiveness. However, he also outlines strategic responses diversifying sourcing, embracing AI, and strengthening domestic capabilities that can turn this challenge into an opportunity for long-term sectoral resilience.
Press Room
Indian bioscience industry readies to brace the impact
Recent Press Room
- How battery technology and changing advancements are transforming electric vehicles?
11 Jul 2025
- Indian bioscience industry readies to brace the impact
11 Jul 2025
- Why Indian methanol producers will miss the “Methanol Economy” bus
11 Jul 2025
- National Technology Day: Celebrating India’s Innovation Journey
4 Jul 2025
- Views on ChatGPT’s New Shopping Feature
11 Jun 2025